Skip to content

Treatment of Ilioinguinal Entrapment Syndrome - an Often Overlooked Cause of Chronic Pelvic Pain

Treatment of Ilioinguinal Entrapment Syndrome - a Randomised Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01020162
Enrollment
19
Registered
2009-11-25
Start date
1995-09-30
Completion date
2007-11-30
Last updated
2009-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pelvic Pain

Keywords

Chronic pelvic pain, ilioinguinal nerve entrapment, randomized study, Chronic pelvic pain in women

Brief summary

Neuralgic pain caused by entrapment of peripheral nerves is an often overlooked cause of chronic pelvic pain. The objective of the present study was to assess pain and quality of life in women with pain caused by entrapment of the ilioinguinal nerve, iatrogenic after surgery but also found without previous surgery. In a controlled prospective cross-over study 19 women were randomized either to medical treatment or to resection of the nerve. Statistically significant improvements were found after surgical resection.

Interventions

DRUGAmitryptiline, gabapentin

For amitryptiline starting dose 20-30 mg at night, increasing until clinical effect. For gabapentin was the initial dose 300 mg tid with rapid increases up to 800 mg tid.

PROCEDUREResection of the ilioinguinal nerve

In general anaesthesia the nerve was identified and resected as central as possible

Sponsors

Göteborg University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
15 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Pelvic pain in which a careful investigation has shown signs of ilioinguinal nerve entrapment

Exclusion criteria

* Drug abuse

Design outcomes

Primary

MeasureTime frame
Improvements in pain according to Visual Analogue Scales. Improvements in quality of life according to Psychological General Well-Being-scales.At least one year after intervention,in some cases more then five years.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026